Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2020

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    kkjoel
    wrote on sidst redigeret af
    #393

    ..samarbejde med et ledende medicinalfirmas førende..

    1 Reply Last reply
    0
    • K Offline
      K Offline
      kkjoel
      wrote on sidst redigeret af
      #394

      Ups.. samarbejde med et antistof.. don't go there, Jan!

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #395

        Ja ja. dårlig lukkeauktion, men trods alt ny lukkerekord. 🙂

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #396

          it is out in your mail

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #397

            maintaining outlook

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Peter_Panik
              wrote on sidst redigeret af
              #398

              Genmab Q1: Fastholder forventningerne
              Genmab fastholder forventningerne til omsætning og driftsresultatet i 2020 i regnskabet for første kvartal.

              Genmab regner stadig med, at Johnson & Johnson vil lande et Darzalex-salg på 3,9-4,2 mia. dollar i 2020. Det vil give Genmab en royaltyindtægt på omkring 4075-4475 mio. kr.

              Forventningerne til den samlede omsætning er uændret 4750-5150 mio. kr. Der ventes driftsomkostninger på 3850-3950 mio. kr., og et driftsresultat på 850-1250 mio. kr.

              Analytikere

              1 Reply Last reply
              0
              • A Offline
                A Offline
                AaBforever
                wrote on sidst redigeret af
                #399

                Vel som forventet.

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #400

                  Gen­mab går fri af cor­ona­kri­se: Øger om­sæt­nin­gen med 51 pct

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #401

                    Link Preview Image
                    Genmab går fri af coronakrise: Øger omsætningen med 51 pct

                    Biotekselskabet Genmab har i første kvartal sneget sig rundt om coronakrisen og øget selskabets omsætning. Det fremgår af Genmabs regnskab, der er blevet offentliggjort onsdag. Salget endte i årets tr

                    favicon

                    borsen.dk (borsen.dk)

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #402

                      @Sukkeralf
                      January: First Clinical Trial Applications (CTAs) submitted for DuoBody-CD3x5T4 in Europe.

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #403

                        Nice - that was early 🙂

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #404

                          small milestone payments, DKK 32 million, under
                          our DuoBody collaboration with Novo Nordisk and our Teprotumumab collaboration with Horizon
                          Therapeutics.

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #405

                            "Genmab overrasker positivt med sit regnskab for første kvartal, hvor både omsætning og driftsindtjening gik frem, samtidig med at bundlinjen blev løftet af markant højere finansindtægter."/ritzau/FINANS

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #406

                              He he, cash position 12,69mia dkk

                              1 Reply Last reply
                              0
                              • Legolas23L Offline
                                Legolas23L Offline
                                Legolas23
                                wrote on sidst redigeret af
                                #407

                                Operating expenses were DKK 821 million in the first quarter of 2020 compared to DKK 617 million in the first quarter of 2019. The increase of DKK 204 million, or 33%, was driven by the advancement of epcoritamab (DuoBody®-CD3xCD20) and DuoBody-PD-L1x4-1BB, additional investments in our product pipeline, and the increase in new employees to support the expansion of our product pipeline..

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #408

                                  Vor oversøiske pandang-aktie er i ATH https://www.google.com/search?q=gmab+nasdaq&oq=gmab+&aqs=chrome.2.69i57j0l2j69i60l2.8636j0j7&client=ms-unknown&sourceid=chrome-mobile&ie=UTF-8

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #409

                                    1760 med $25,48

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #410

                                      Lidt optimisme hos JW om lidt og vi har ny ATH i morgen 😉

                                      1 Reply Last reply
                                      0
                                      • Legolas23L Offline
                                        Legolas23L Offline
                                        Legolas23
                                        wrote on sidst redigeret af
                                        #411

                                        Næsten i 26$ nu !!!

                                        1 Reply Last reply
                                        0
                                        • troldmandenT Offline
                                          troldmandenT Offline
                                          troldmanden
                                          wrote on sidst redigeret af
                                          #412

                                          IMS U.S. weekly gross sales are down ~15% compared to avg. 4W sales as of end of March and are currently at ~$40 million per week*

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger